On 23 March two directors and one of the senior management team purchased shares. Shaun Chilton bought 10,000 shares, Nick Keher 6,200 shares and David Bryant 4,763 shares. These investments provide reassurance at the current time and we rate the shares as a BUY.
Clinigen Group – 430p
